HOGAN LOVELLS US LLP

Lobbying for CELLARES CORPORATION · Integrated Development and Manufacturing Organization (IDMO) - Cell Therapy Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 13, 2026

Lobbying activity 1

Health Issues

Patient access to biotechnology innovation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.